Role of Genetics in Post Thrombolysis Patients (RTPA); Targeting Optimal Thrombolysis Outcomes Study

Lead PI: Prof Chris Levi

Status: Recruiting

No. of Patients Currently Recruited: 200                               No. of Patients Required: 300

TOTO is collecting biological samples, imaging and clinical data to examine predictors of stroke outcome, particularly in patients who undergo thrombolysis or thrombectomy. The biological samples consist of serum, plasma and genetic material collected both before and after acute therapy, and in some cases, clots retrieved via thrombectomy.  

Trial URL: 

23 June 2021

Related Posts